We are live on ! Find out more
NEXI

NexImmune, Inc. Common Stock
NEXI

Delisted

NEXI was delisted on the 11th of July, 2024.

Back to rankings

46 hedge funds and large institutions have $47.1M invested in NexImmune, Inc. Common Stock in 2021 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 12 increasing their positions, 11 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

9% more repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 11

2% less funds holding

Funds holding: 47 → 46 (-1)

11% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 9

71% less capital invested

Capital invested by funds: $160M → $47.1M (-$113M)

Holders
46
Holders Change
-1
Holders Change %
-2.13%
% of All Funds
0.71%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
12
Reduced
11
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
JMPWA
JP Morgan Private Wealth Advisors
California
+$961K
2
Renaissance Technologies
Renaissance Technologies
New York
+$489K
3
Morgan Stanley
Morgan Stanley
New York
+$340K
4
BlackRock
BlackRock
New York
+$320K
5
State Street
State Street
Massachusetts
+$318K

Top Sellers

Rank Fund Capital Flow
1
SCM
Suvretta Capital Management
New York
-$5.21M
2
TCM
TimesSquare Capital Management
New York
-$2.29M
3
ACH
ArrowMark Colorado Holdings
Colorado
-$1.5M
4
RJA
Raymond James & Associates
Florida
-$393K
5
Victory Capital Management
Victory Capital Management
Texas
-$181K
Name Holding Trade Value Shares
Change 		Change in
Stake
ACH
1
ArrowMark Colorado Holdings
Colorado
$8.31M -$1.5M -6,224 -8%
AG
2
Artal Group
Luxembourg
$5.53M – – –
SPC
3
Slate Path Capital
New York
$4.26M – – –
BlackRock
4
BlackRock
New York
$3.9M +$320K +1,333 +4%
Adage Capital Partners
5
Adage Capital Partners
Massachusetts
$3.69M – – –
Vanguard Group
6
Vanguard Group
Pennsylvania
$3.15M +$25.2K +105 +0.4%
AO
7
Allen Operations
New York
$2.93M – – –
Fidelity Investments
8
Fidelity Investments
Massachusetts
$2.42M – – –
BM
9
Bridger Management
New York
$1.84M – – –
BBA
10
Baker Bros. Advisors
New York
$1.36M – – –
JP Morgan Chase
11
JP Morgan Chase
New York
$1.22M -$36.3K -151 -1%
TCM
12
TimesSquare Capital Management
New York
$998K -$2.29M -9,526 -52%
Geode Capital Management
13
Geode Capital Management
Massachusetts
$903K -$158K -659 -8%
State Street
14
State Street
Massachusetts
$900K +$318K +1,322 +20%
First Manhattan
15
First Manhattan
New York
$678K – – –
Northern Trust
16
Northern Trust
Illinois
$644K -$25.9K -108 -2%
MCM
17
M28 Capital Management
Connecticut
$615K +$1.28M +5,338 New
KCM
18
Kingdon Capital Management
New York
$544K – – –
6CM
19
683 Capital Management
New York
$464K – – –
JMPWA
20
JP Morgan Private Wealth Advisors
California
$461K +$961K +4,000 New
Millennium Management
21
Millennium Management
New York
$284K -$93.2K -388 -14%
Edgewood Management
22
Edgewood Management
Connecticut
$258K – – –
Renaissance Technologies
23
Renaissance Technologies
New York
$235K +$489K +2,036 New
Bank of New York Mellon
24
Bank of New York Mellon
New York
$189K -$5.04K -21 -1%
Morgan Stanley
25
Morgan Stanley
New York
$174K +$340K +1,415 +1,522%
1
2 3

NEXI Hedge Fund Activity: Q4 2021 in Review

46 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in NexImmune, Inc. Common Stock (NEXI) for Q4 2021, worth a combined $47.1M — down 71% from $160M a quarter earlier.

Sellers outnumbered buyers: 9 funds closed out of NEXI and 8 opened new positions — a net loss of 1 holder — while 11 trimmed existing stakes and 12 added.

The largest buyer was JP Morgan Private Wealth Advisors, opening a new position worth an estimated $961K. The largest seller was Suvretta Capital Management, exiting entirely with an estimated $5.21M sold.

  • 46 institutional investors held NexImmune, Inc. Common Stock (NEXI) as of Q4 2021, down from 47 in Q3 2021.
  • Funds reported $47.1M of NexImmune, Inc. Common Stock stock for Q4 2021, down 71% quarter-over-quarter.
  • 8 funds opened new NexImmune, Inc. Common Stock positions in Q4 2021 and 9 closed out, a net change of -1 holder.
  • The largest NexImmune, Inc. Common Stock buyer in Q4 2021 was JP Morgan Private Wealth Advisors, an estimated $961K added.
  • The largest NexImmune, Inc. Common Stock seller in Q4 2021 was Suvretta Capital Management, an estimated $5.21M sold.

Based on aggregated 13F filings for Q4 2021.